Limited evidence for clinical validity, utility of ctDNA
(HealthDay)—There is little evidence for the clinical validity or utility of circulating tumor DNA (ctDNA) assays for solid tumors, according to a special article published online March 5 in the Journal of Clinical Oncology.
Mar 5, 2018
0
3